RECURRENT MELANOMA
Clinical trials for RECURRENT MELANOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MELANOMA trials appear
Sign up with your email to follow new studies for RECURRENT MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets tough cancers using biomarker clues
Disease control Recruiting nowThis study tests two drugs, cabozantinib and nivolumab, in 150 people with advanced melanoma or head and neck cancer that hasn't responded to prior immunotherapy. The goal is to see if the combination shrinks tumors and how quickly doctors can use tumor biomarkers to sort patient…
Matched conditions: RECURRENT MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Engineered immune cells take on hard-to-treat melanoma in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment made from a person's own immune cells (NK cells) that are engineered to recognize and attack melanoma cells carrying a protein called PRAME. The study enrolls adults with advanced melanoma that has not responded to standard immunothera…
Matched conditions: RECURRENT MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:39 UTC